Healthcare Financial Management Association 2023

What Can Robotic Process Automation Mean for the Longevity of the Healthcare System?

In the current climate, healthcare systems are facing increased financial strain due to the ongoing effects of the pandemic. This reality, combined with the continuous pressure to reduce costs and improve efficiency, calls for innovative, solutions-oriented strategies that break away from traditional dependency models. The emerging role of Robotic Process Automation (RPA) and machine…

Read More

Latest

Articles
Inpatient Nursing Needs Efficient, Innovative Technology to Boost Staff Morale

Navigating the intricate landscape of inpatient nursing can be a daunting task, especially with the rising wage rates posing significant challenges. It is vital, now more than ever, to implement innovative solutions that not only ensure equitable staffing ratios but also enhance the overall work experience of healthcare professionals.  Implementing efficient cost cutting measures…

Read More
Health
Bridging the Gap: Tech-Enabled, Physician-Led Clinical Documentation Solutions

Healthcare brings in plenty of money via payments and funding, but due to a lack of coding solutions, not all healthcare professionals get paid for their work. Even if a physician goes get paid, it can take some time, or some of the work they have done gets lost in the cracks, along with…

Read More
Health
Up-leveling the Consumer Experience in Healthcare

Highway to Health’s David Kemp attended HFMA 2023 in Nashville and got some interesting insights on up-leveling the consumer experience in healthcare. Seth Cohen, President of Cedar, and Jeremy Church, CFO at Keck Medicine of USC, took a moment to sit down and discuss the importance of enhancing the patient experience through digital engagement strategies….

Read More
Articles
Virtual Nursing is a Direct Response to Recent Issues in Healthcare Says the Company Leading the Charge

Virtual nursing is a fairly new concept but it’s likely to be crucial in the future healthcare solutions. Due to a lot of data-driven decision-making in various fields, healthcare is no exception, with organizations increasingly leveraging data to streamline processes, improve financial health, and enhance patient care. As the sector grapples with challenges like…

Read More
Articles
A Changing Healthcare Landscape is Pressuring Costs on the Industry, But Technology is Swinging in With a Resolution

With an evolving healthcare landscape, organizations face increasing pressure on their profit margins, stemming from rising labor and supply costs, declining reimbursements, and the intricate dynamics of healthcare billing. Striking a balance amid these challenges requires innovative strategies and tools to measure, motivate, and retain the highest performers – the human capital that ultimately…

Read More

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More